Fate Therapeutics, Inc. FATE
1.01 USD -0.04 (-3.81%)
Regular-session close
1.05 +0.04 +3.79%
After hours · Nov 19, 7:13 PM ET
1.01 Day range 1.07
0.95 52-week range 3.23
- YTD
- +3.06%
- 1 year
- -3.81%
FATE revenue history
Revenue is income from the company’s ordinary business activities.
6,646,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 6,646,000 | -6,985,000 | -51.24% |
| FY 2024 | 2024-12-31 | 13,631,000 | -49,902,000 | -78.55% |
| FY 2023 | 2023-12-31 | 63,533,000 | -32,767,000 | -34.03% |
| FY 2022 | 2022-12-31 | 96,300,000 | 40,454,000 | 72.44% |
| FY 2021 | 2021-12-31 | 55,846,000 | 24,412,000 | 77.66% |
| FY 2020 | 2020-12-31 | 31,434,000 | 20,754,000 | 194.33% |
| FY 2019 | 2019-12-31 | 10,680,000 | 5,940,000 | 125.32% |
| FY 2018 | 2018-12-31 | 4,740,000 | 634,000 | 15.44% |
| FY 2017 | 2017-12-31 | 4,106,000 | -296,000 | -6.72% |
| FY 2016 | 2016-12-31 | 4,402,000 | 1,971,000 | 81.08% |
| FY 2015 | 2015-12-31 | 2,431,000 | 2,431,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | -971,000 | -100.00% |
| FY 2013 | 2013-12-31 | 971,000 | -1,699,000 | -63.63% |
| FY 2012 | 2012-12-31 | 2,670,000 | 1,500,000 | 128.21% |
| FY 2011 | 2011-12-31 | 1,170,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:03.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
